Compositions and methods for altering immune function

Details Compositions and methods for altering immune function Compositions and methods for altering immune function

2006-06-01

2009-10-13

Szperka, Michael (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S138100, C424S118000

Reexamination Certificate

active

07601355

ABSTRACT:
The present invention relates to molecules that stabilize and/or enhance CD154 activity, compositions comprising these molecules, methods for using these molecules and compositions (e.g., pharmaceutical compositions) comprising them. Specifically, the molecules can be used for enhancing immune function (e.g., enhancing Th1 cytokine expression), stimulating immune responses, and/or treating certain disorders (e.g., cancer, infectious disease, and immune compromised states). The invention also relates to kits and compositions comprising the molecules.

REFERENCES:
patent: 5679347 (1997-10-01), Porcelli
patent: 5776427 (1998-07-01), Thorpe
patent: 6238676 (2001-05-01), Porcelli
patent: 2003/0176377 (2003-09-01), Xiang et al.
patent: 2004/0006208 (2004-01-01), Karpusas et al.
patent: 2004/0191248 (2004-09-01), Goldenberg et al.
patent: 2005/0084490 (2005-04-01), Adams
patent: 2007/053189 (2007-05-01), None
Kuby, Immunology, 1994, p. 1-20.
Gurunathan et al.,J. Immunology, 1998, vol. 161, p. 4563-4571.
Banchereau and Steinman, “Dendritic cells and the control of immunity” 1998 Nature 392:245.
Banchereau et al., “Molecular control of B-cell immunopoiesis” 1994 Ann. N Y Acad. Sci. 725:22-23.
Burdin et al., “Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes” 1996 J. Immunol. 156:4107.
Cohen et al., “CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens” 1994 Cancer Research 54:1055-8.
Estes et al., “CD40 ligand-dependent signaling of bovine B lymphocyte development and differentiation” Vet. Immunol. Immunopathol. 1998, 63:15-20.
Foy et al., “gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory” J. Exp. Med. 1994, 180:157-63.
Gurunathan et al., “CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge” 1998 J. Immunol. 161:4563-71.
Haas and Estes, “Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes” 2000 Immunology 99:272.
Hirano et al., “Kinetics of expression and subset distribution of the TNF superfamily members CD40 ligand and Fas ligand on T lymphocytes in cattle” Vet. Immunol. Immonpathol. 1998, 61:251-63.
Kuby, “Overview of the Immune System,” Immunology 1994, p. 1-20.
Ludmerer et al., “HPV11 Mutant Virus-like Particles Elicit Immune Responses That Neutralize Virus and Delineate a Novel Neutralizing Domain” Virology Jan. 20, 2000 266(2):237-45.
Mendoza et al., “Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization” 1997 J. Immunol. 159:5777.
Mertens et al., “Cloning of two members of the TNF-superfamily in cattle: CD40 ligand and tumor necrosis factor alpha” 1995 Immunogenetics 42:430-1.
Rolph et al. “CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogenListeria monocytogenes,” J. Immunology 2001 v166 p. 5115.
Sin et al., “Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo” 2001 Hum. Gene Ther. 12:1091-102.
Tripp et al., “CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse” 2000 J. Immunol. 164:5913.
Van Kooten and Banchereau, “C040-C040 Ligand: A Multifunctional Receptor-Ligand Pair” 1996 Adv. Immunol. 61:1.
Van Kooten et al., “CD40-CD40 ligand” 2000 Leukocyte Biol. 67:2.

Affiliated with

Also associated with

Rating

Compositions and methods for altering immune function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for altering immune function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for altering immune function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4140710